Clinical trial NCT05066061: Virtual Reality and Peripheral Intravenous Catheter Insertion to Children (R3VP)
Official title: Study of the Contribution of Virtual Reality Distraction in Peripheral Intravenous Catheter Insertion to Children From 6 to 11 Years in a Pediatric Day Hospital
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Virtual Reality
Catheterization, Peripheral Venous
Children, Only
Pain, Procedural
Keywords: virtual reality mask
children from 6 to 11
peripheral intravenous catheter insertion
pediatric's day hospital
Lead sponsor: University Hospital, Clermont-Ferrand
Sponsor class: OTHER
First posted: 2021-10-04
Enrollment: 210
Sex: ALL
Minimum age (years): 6
Maximum age (years): 11
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized, controlled, open-label, three-arm parallel, single-center therapeutic trial.
Primary purpose: PREVENTION

Brief summary: Main objective :

Evaluate the effect of using a virtual reality mask during the peripheral intravenous catheter insertion in a pediatric day hospital on the pain and anxiety in children from 6 to 11 years old.

Hypothesis :

Using virtual reality mask during the peripheral intravenous catheter insertion would reduce the 6 to 11 child's pain, the children and parents' anxiety, would improve satisfaction of children, parents and nurse about the care and would reduce time and cost of the procedure.

Detailed description: Peripheral intravenous catheter insertion is a difficult, painful and anxiety-provoking procedure for hospitalized children, with the possible memorization of pain being even more present for children with chronic pathologies.

Memorization of painful events plays an essential role in anticipating the next experience and can lead to long-term consequences. The child, whose cognitive faculties are gradually developing and whose emotions are very invasive, is particularly concerned by this repercussion.

Different techniques can be used to prevent pain during care (apart from "human" techniques such as comfort, distraction by voice, information on gesture... which are part of good practice).

The national drug safety agency recommends the use of the local anesthetic cream and/or an equimolar mixture of oxygen and nitrous oxide causing surface anesthesia and relaxation and amnesia of the gesture.

Immersion in virtual reality allows to saturate the child's sensorially (3D vision, hearing and kinesthetic proprioception) thus reducing nociceptive perceptions and anxiety. His attention is focused by the virtual animation proposed during this experience. There are many devices (glasses, masks...) as well as various programs more or less specific to care situations, some of them allow to interact with games.

There is no randomized study comparing the efficacy on pain, satisfaction and anxiety of peripheral intravenous catheter insertion with the three possible analgesia techniques: local anesthetic cream / local anesthetic cream and anesthetic and anxiolytic gas / local anesthetic cream and virtual reality mask, nor on the medico-economic impact respecting standard 6 on homogeneous pediatric age groups in clinical trials.

This is a randomized, open-label, three-armed, parallel, single-center therapeutic trial comparing an analgesic strategy using two authorized medical devices (conventional strategy) with a virtual reality mask distraction technique for intravenous catheter insertion in children aged 6 to 11 years old hospitalized in the day hospital of Clermont Ferrand University Hospital.

The control arm is the local anesthetic cream arm, the experimental arms are the local anesthetic cream + anesthetic and anxiolytic gas arm on the one hand and the local anesthetic cream + virtual reality mask type Oculus quest® with interactive program on the other hand.

After informing and obtaining the consent of the child and his parents, will be measured the pain/anxiety/salivary cortisol/heart rate of the child; anxiety of the parents. The nurse evaluates the venous capital of the child then times the time of care and collects (among other things) the number of operators required. Immediately after the treatment, and then 15 to 30 minutes after the insertion will be measured the pain/anxiety/heart rate of the child; anxiety of the parents. The salivary cortisol at 20 minutes after catheter insertion will reflect the stress felt by the child during the procedure. Finally, the satisfaction of the child, parents, nurses will be collected 30 minutes after the care.

After statistical analysis of these three arms, it will be possible to determine the value of the anesthetic and anxiolytic gas and the virtual reality mask to reduce the child's pain and anxiety during the intravenous catheter insertion.

Eligibility criteria: Inclusion Criteria:

* Children from 6 to 11 years old requiring an intravenous catheter insertion in a pediatric day hospital at the Clermont Ferrand University Hospital.
* Subjects and their parents who were informed about the study and gave informed consent
* Subjects who have had local anesthetic cream for 1-5 hours at the puncture site
* On the first attempt to apply intravenous catheter on the day of inclusion
* Subjects and their parents able to use the self-report scales proposed in the study.

Exclusion Criteria:

Children from 6 to 11 :

* Having a modification of pain's integration (spina bifida for example)
* Having received an analgesic before the care
* Requiring contact isolation
* With a history of seizures or motion sickness
* Born very prematurely (\< 28 SA)
* Presenting a contraindication to the use of the local anesthetic cream
* Presenting a contraindication to the use of the anesthetic and anxiolytic gas.
* Presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post traumatic stress syndrome)

Primary outcomes:
measure: change from baseline child's pain at 30 minutes after the care
timeFrame: - Before the care - Immediately after the care - 15 to 30 minutes after the care
Secondary outcomes:
measure: change from baseline child's anxiety at 30 minutes after the care
timeFrame: -before the care -immediately after the care -15 to 30 minutes after the care
measure: change from baseline heart rate at 30 minutes after the care
timeFrame: -before the care -immediately after the care -15 to 30 minutes after the care
measure: change from baseline salivary cortisol at 30 minutes after the care
timeFrame: -before the care -15 to 30 minutes after the care
measure: change from baseline parents' anxiety at 30 minutes after the care
timeFrame: -before the care - immediately after the care - 15 to 30 minutes after the care
measure: evaluation of the care with satisfaction questionnaire
timeFrame: 30 minutes after the care
Other outcomes:
Locations:
city: Clermont-Ferrand
country: France
facility: CHU de Clermont-Ferrand
Study officials:
affiliation: ClermontFerrandUH
name: EMMANUELLE LABRAISE, NURSE
role: PRINCIPAL_INVESTIGATOR
References: